Allergy Immunotherapy in the United States

Published: April 28, 2020

market watch 500

Click the link below to read a brief summary of a new report from Future Market Insights that analyzes the allergy immunotherapy market in the United States. “According to the study, growing focus on taking preventive measures against chronic illnesses is also catalyzing the allergy immunotherapy market.”

Interestingly, the report also found that, “Depending on the treatment type, the sublingual immunotherapy drugs segment is expected to hold a prominent share in the allergy immunotherapy market during the forecast period.”

As a complete allergy immunotherapy solution for both offices and hospital systems, Edge has everything required to manage and deliver allergy immunotherapy to your patients. This includes Xtract Immunotherapy Software, bulk extracts, testing and administration supplies, outsourced compounding of both SCIT and SLIT treatment sets, and consulting and training services. Learn more about our products and services at edgepharma.com/allergy and xtractsolutions.com.